134 related articles for article (PubMed ID: 2872717)
1. Evidence of somatostatin as a humoral modulator of motilin release in man. A study of plasma motilin and somatostatin during intravenous infusion of somatostatin, secretin, cholecystokinin, and gastric inhibitory polypeptide.
Jenssen TG; Haukland HH; Florholmen J; Jorde R; Burhol PG
Scand J Gastroenterol; 1986 Apr; 21(3):273-80. PubMed ID: 2872717
[TBL] [Abstract][Full Text] [Related]
2. Effects of motilin and octapeptide of cholecystokinin on antral and duodenal myoelectric activity in the interdigestive state and during inhibition by secretin and gastric inhibitory polypeptide.
Castresana M; Lee KY; Chey WY; Yajima H
Digestion; 1978; 17(4):300-8. PubMed ID: 669076
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal regulatory peptides during oxytocin infusion in post-term pregnancies.
Holst N; Jenssen TG; Burhol PG; Jorde R
Acta Physiol Scand; 1988 Jan; 132(1):23-7. PubMed ID: 2906209
[TBL] [Abstract][Full Text] [Related]
4. Effects of the somatostatin analog BIM 23014 on the secretion of growth hormone, thyrotropin, and digestive peptides in normal men.
Sassolas G; Khalfallah Y; Chayvialle JA; Cohen R; Merabet S; Casez JP; Calvet P; Cabrera P
J Clin Endocrinol Metab; 1989 Feb; 68(2):239-46. PubMed ID: 2563730
[TBL] [Abstract][Full Text] [Related]
5. Release of pancreatic and gastric somatostatin-like immunoreactivity in response to the octapeptide of cholecystokinin, secretin gastric inhibitory polypeptide, and gastrin-17 in dogs.
Rouiller D; Schusdziarra V; Harris V; Unger RH
Endocrinology; 1980 Aug; 107(2):524-9. PubMed ID: 6104593
[No Abstract] [Full Text] [Related]
6. Effect of secretin on plasma motilin in man.
Mitznegg P; Bloom SR; Domschke W; Haecki WH; Domschke S; Belohlavek D; Wünsch E; Demling L
Gut; 1977 Jun; 18(6):468-71. PubMed ID: 17563
[TBL] [Abstract][Full Text] [Related]
7. The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.
Ipp E; Dobbs RE; Harris V; Arimura A; Vale W; Unger RH
J Clin Invest; 1977 Nov; 60(5):1216-9. PubMed ID: 908761
[TBL] [Abstract][Full Text] [Related]
8. Effect of cholecystokinin, secretin, and gastric inhibitory polypeptide on insulin release from the isolated perfused rat pancreas.
Pederson RA; Brown JC
Can J Physiol Pharmacol; 1979 Nov; 57(11):1233-7. PubMed ID: 519526
[TBL] [Abstract][Full Text] [Related]
9. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.
Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY
Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501
[TBL] [Abstract][Full Text] [Related]
10. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
[TBL] [Abstract][Full Text] [Related]
11. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
Szecówka J; Lins PE; Efendić S
Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous somatostatin and motilin on the blood glucose and hormonal response to oral glucose.
Long RG; Christofides ND; Fitzpatrick ML; O'Shaughnessy DJ; Bloom SR
Eur J Clin Invest; 1982 Aug; 12(4):331-6. PubMed ID: 6128230
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of gastric inhibitory polypeptide, cholecystokinin, and somatostatin on the serum levels of cationic trypsin-like immunoreactivity in man.
Florholmen J; Burhol PG; Jenssen TG; Jorde R
Scand J Gastroenterol; 1985 Sep; 20(7):829-34. PubMed ID: 2864738
[TBL] [Abstract][Full Text] [Related]
14. Effect of a combination of gastrin, secretin, cholecystokinin, glucagon, and gastric inhibitory polypeptide on jejunal absorption in man.
Poitras P; Modigliani R; Bernier JJ
Gut; 1980 Apr; 21(4):299-304. PubMed ID: 7429291
[TBL] [Abstract][Full Text] [Related]
15. The effect of graded doses of secretin on serum trypsin, serum pancreatic amylase, serum insulin, plasma somatostatin, and plasma pancreatic polypeptide in man.
Florholmen J; Burhol PG; Jorde R; Waldum HL
Scand J Gastroenterol; 1984 Jan; 19(1):24-30. PubMed ID: 6200924
[TBL] [Abstract][Full Text] [Related]
16. Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin.
Itoh H; Nagano T; Takeyama M
Biol Pharm Bull; 2001 Sep; 24(9):1072-5. PubMed ID: 11558572
[TBL] [Abstract][Full Text] [Related]
17. The effects of secretin on prolactin, estradiol, vasoactive intestinal polypeptide, and somatostatin levels in women.
Holst N; Jenssen TG; Burhol PG; Haug E
Acta Endocrinol (Copenh); 1990 Mar; 122(3):313-8. PubMed ID: 1970210
[TBL] [Abstract][Full Text] [Related]
18. Effects of pancreatic polypeptide on motilin and circulating metabolites in man.
Adrian TE; Greenberg GR; Barnes AJ; Christofides ND; Alberti KG; Bloom SR
Eur J Clin Invest; 1980 Jun; 10(3):235-40. PubMed ID: 6783420
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones.
O'Shaughnessy DJ; Long RG; Adrian TE; Christofides ND; Ghatei MA; Sarson DL; Bloom SR
Digestion; 1985; 31(4):234-42. PubMed ID: 2861129
[TBL] [Abstract][Full Text] [Related]
20. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
